HMR 1098 is not an SUR isotype specific inhibitor of heterologous or sarcolemmal KATP channels

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 3, 2011, Pages 552-560

  Zhang, Hai Xia ^a   Akrouh, Alejandro ^a   Kurata, Harley T ^a,b   Remedi, Maria Sara ^a   Lawton, Jennifer S ^a   Nichols, Colin G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cardiomyocyte; Insulin; Nucleotide; Patch clamp; Sulfonylurea

Indexed keywords

ADENOSINE DIPHOSPHATE MAGNESIUM; ADENOSINE TRIPHOSPHATE MAGNESIUM; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CLAMIKALANT; GLUCOSE; HM 1098; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; PINACIDIL; RUBIDIUM 86; SULFONYLUREA RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STIMULATION; CELL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HEART ATRIUM; HEART MUSCLE CELL; HEART VENTRICLE WALL; HETEROLOGOUS EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; SARCOLEMMA; WHOLE CELL;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BENZAMIDES; BLOOD GLUCOSE; DIAZOXIDE; INSULIN; ISLETS OF LANGERHANS; KATP CHANNELS; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; PINACIDIL; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG; SARCOLEMMA; SUBSTRATE SPECIFICITY;

MURINAE;

EID: 79551610690     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.12.011     Document Type: Article

References (48)

1. Ashcroft F.M. Adenosine 5'-triphosphate-sensitive potassium channels. Annu Rev Neurosci 1988, 11:97-118.
2. ATP channel complex. J Gen Physiol 1997 Dec, 110(6):655-664.
3. Clement J.P.T., Kunjilwar K., Gonzalez G., Schwanstecher M., Panten U., Aguilar-Bryan L., et al. Association and stoichiometry of K(ATP) channel subunits. Neuron 1997 May, 18(5):827-838.
4. Inagaki N., Gonoi T., Clement JPt, Namba N., Inazawa J., Gonzalez G., et al. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995 Nov 17, 270(5239):1166-1170.
5. Baron A., van Bever L., Monnier D., Roatti A., Baertschi A.J. A novel K(ATP) current in cultured neonatal rat atrial appendage cardiomyocytes. Circ Res 1999 Oct 15, 85(8):707-715.
6. Yokoshiki H., Sunagawa M., Seki T., Sperelakis N. Antisense oligodeoxynucleotides of sulfonylurea receptors inhibit ATP-sensitive K+ channels in cultured neonatal rat ventricular cells. Pflugers Arch 1999 Feb, 437(3):400-408.
7. Morrissey A., Parachuru L., Leung M., Lopez G., Nakamura T.Y., Tong X., et al. Expression of ATP-sensitive K+ channel subunits during perinatal maturation in the mouse heart. Pediatr Res 2005 Aug, 58(2):185-192.
8. ATP channel subunits in mouse and rat cardiac myocytes and the coronary vasculature. BMC Physiol 2005, 5(1):1.
9. ATP channel subunits and energy metabolism. Circ Res 2008 Feb 1, 102(2):e20-e35.
10. ATP channels require SUR1. Circ Res 2008 Dec 5, 103(12):1458-1465.
11. Glukhov A.V., Flagg T.P., Fedorov V.V., Efimov I.R., Nichols C.G. Differential K(ATP) channel pharmacology in intact mouse heart. J Mol Cell Cardiol 2009, 48(1):152-160.
12. Isidoro Tavares N., Philip-Couderc P., Baertschi A.J., Lerch R., Montessuit C. Angiotensin II and tumour necrosis factor alpha as mediators of ATP-dependent potassium channel remodelling in post-infarction heart failure. Cardiovasc Res 2009 Sep 1, 83(4):726-736.
13. Garrino M.G., Plant T.D., Henquin J.C. Effects of putative activators of K+ channels in mouse pancreatic beta-cells. Br J Pharmacol 1989 Nov, 98(3):957-965.
14. Inagaki N., Gonoi T., Clement J.P., Wang C.Z., Aguilar-Bryan L., Bryan J., et al. A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron 1996 May, 16(5):1011-1017.
15. Yokoshiki H., Sunagawa M., Seki T., Sperelakis N. ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol 1998 Jan, 274(1 Pt 1):C25-C37.
16. Billman G.E., Englert H.C., Scholkens B.A. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J Pharmacol Exp Ther 1998 Sep, 286(3):1465-1473.
17. Wirth K.J., Uhde J., Rosenstein B., Englert H.C., Gogelein H., Scholkens B.A., et al. K(ATP) channel blocker HMR 1883 reduces monophasic action potential shortening during coronary ischemia in anesthetised pigs. Naunyn Schmiedebergs Arch Pharmacol 2000 Feb, 361(2):155-160.
18. Kaab S., Zwermann L., Barth A., Hinterseer M., Englert H.C., Gogelein H., et al. Selective block of sarcolemmal IKATP in human cardiomyocytes using HMR 1098. Cardiovasc Drugs Ther 2003 Sep-Nov, 17(5-6):435-441.
19. Manning Fox J.E., Kanji H.D., French R.J., Light P.E. Cardioselectivity of the sulphonylurea HMR 1098: studies on native and recombinant cardiac and pancreatic K(ATP) channels. Br J Pharmacol 2002 Jan, 135(2):480-488.
20. Weyermann A., Vollert H., Busch A.E., Bleich M., Gogelein H. Inhibitors of ATP-sensitive potassium channels in guinea pig isolated ischemic hearts. Naunyn Schmiedebergs Arch Pharmacol 2004 Apr, 369(4):374-381.
21. Vajda S., Baczko I., Lepran I. Selective cardiac plasma-membrane K(ATP) channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion. Eur J Pharmacol 2007 Dec 22, 577(1-3):115-123.
22. Zhu B.M., Miyamoto S., Nagasawa Y., Wajima T., Hashimoto K. Effect of the sarcolemmal K(ATP) channel blocker HMR1098 on arrhythmias induced by programmed electrical stimulation in canine old myocardial infarction model: comparison with glibenclamide. J Pharmacol Sci 2003, 93(1):106-113.
23. ATP channel triggers delayed ischemic preconditioning in rats. Am J Physiol Heart Circ Physiol 2005 Jan, 288(1):H445-H447.
24. Diodato M.D., Shah N.R., Prasad S.M., Gaynor S.L., Lawton J.S., Damiano R.J. Donor heart preservation with pinacidil: the role of the mitochondrial K ATP channel. Ann Thorac Surg 2004 Aug, 78(2):620-626. discussion 6-7.
25. Driamov S., Bellahcene M., Ziegler A., Barbosa V., Traub D., Butz S., et al. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels. Basic Res Cardiol 2004 Jul, 99(4):299-308.
26. Fischbach P.S., White A., Barrett T.D., Lucchesi B.R. Risk of ventricular proarrhythmia with selective opening of the myocardial sarcolemmal versus mitochondrial ATP-gated potassium channel. J Pharmacol Exp Ther 2004 May, 309(2):554-559.
27. Suzuki M., Saito T., Sato T., Tamagawa M., Miki T., Seino S., et al. Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice. Circulation 2003 Feb 11, 107(5):682-685.
28. Marinovic J., Bosnjak Z.J., Stadnicka A. Distinct roles for sarcolemmal and mitochondrial adenosine triphosphate-sensitive potassium channels in isoflurane-induced protection against oxidative stress. Anesthesiology 2006 Jul, 105(1):98-104.
29. Villareal D.T., Koster J.C., Robertson H., Akrouh A., Miyake K., Bell G.I., et al. Kir6.2 variant E23K increases ATP-sensitive K+ channel activity and is associated with impaired insulin release and enhanced insulin sensitivity in adults with normal glucose tolerance. Diabetes 2009 Aug, 58(8):1869-1878.
30. Remedi M.S., Koster J.C., Markova K., Seino S., Miki T., Patton B.L., et al. Diet-induced glucose intolerance in mice with decreased beta-cell ATP-sensitive K+ channels. Diabetes 2004 Dec, 53(12):3159-3167.
31. Remedi M.S., Nichols C.G. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells. PLoS Med 2008 Oct 28, 5(10):e206.
32. ATP channels. Am J Physiol Heart Circ Physiol 2004 Apr, 286(4):H1361-H1369.
33. ATP channels by SUR1 and SUR2A. J Mol Cell Cardiol 2005 Sep, 39(3):491-501.
34. Gribble F.M., Tucker S.J., Ashcroft F.M. The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation. J Physiol 1997 Oct 1, 504(Pt 1):35-45.
35. ATP channels as molecular sensors of cellular metabolism. Nature 2006 Mar 23, 440(7083):470-476.
36. Gogelein H., Hartung J., Englert H.C., Scholkens B.A. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: effects on cardiomyocytes, coronary flow and pancreatic beta-cells. J Pharmacol Exp Ther 1998 Sep, 286(3):1453-1464.
37. Liu Y., Ren G., O'Rourke B., Marban E., Seharaseyon J. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels. Mol Pharmacol 2001 Feb, 59(2):225-230.
38. Babenko A.P., Gonzalez G., Bryan J. The tolbutamide site of SUR1 and a mechanism for its functional coupling to K(ATP) channel closure. FEBS Lett 1999 Oct 15, 459(3):367-376.
39. Zunkler B.J., Lins S., Ohno-Shosaku T., Trube G., Panten U. Cytosolic ADP enhances the sensitivity to tolbutamide of ATP-dependent K+ channels from pancreatic B-cells. FEBS Lett 1988 Nov 7, 239(2):241-244.
40. Schwanstecher C., Dickel C., Panten U. Cytosolic nucleotides enhance the tolbutamide sensitivity of the ATP-dependent K+ channel in mouse pancreatic B cells by their combined actions at inhibitory and stimulatory receptors. Mol Pharmacol 1992 Mar, 41(3):480-486.
41. Gribble F.M., Tucker S.J., Seino S., Ashcroft F.M. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels. Diabetes 1998 Sep, 47(9):1412-1418.
42. Reimann F., Dabrowski M., Jones P., Gribble F.M., Ashcroft F.M. Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides. J Physiol 2003 Feb 15, 547(Pt 1):159-168.
43. Rainbow R.D., Norman R.I., Hudman D., Davies N.W., Standen N.B. Reduced effectiveness of HMR 1098 in blocking cardiac sarcolemmal K(ATP) channels during metabolic stress. J Mol Cell Cardiol 2005 Oct, 39(4):637-646.
44. Salloum F.N., Ockaili R.A., Wittkamp M., Marwaha V.R., Kukreja R.C. Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits. J Mol Cell Cardiol 2006 Mar, 40(3):405-411.
45. Kita H., Miura T., Miki T., Genda S., Tanno M., Fukuma T., et al. Infarct size limitation by bradykinin receptor activation is mediated by the mitochondrial but not by the sarcolemmal K(ATP) channel. Cardiovasc Drugs Ther 2000 Oct, 14(5):497-502.
46. Fryer R.M., Eells J.T., Hsu A.K., Henry M.M., Gross G.J. Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function. Am J Physiol Heart Circ Physiol 2000 Jan, 278(1):H305-H312.
47. Fryer R.M., Hsu A.K., Nagase H., Gross G.J. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels. J Pharmacol Exp Ther 2000 Aug, 294(2):451-457.
48. ATP channel blocker HMR 1098 on cardiac function in isolated perfused working rat hearts and in anesthetized rats during ischemia and reperfusion. Naunyn Schmiedebergs Arch Pharmacol 2001 Jul, 364(1):33-41.